What question did this study set out to answer?

Evaluate the need for standardized reporting in studies using biologics in plastic surgery.

April 21, 2026Open Access

A Commentary on the Need for Minimum Information for Studies Evaluating Biologics in Plastic Surgery

Key Points

Evaluate the need for standardized reporting in studies using biologics in plastic surgery.
Analysis of literature on biologics in plastic surgery
Identification of reporting inconsistencies
Review of MIBO guidelines from orthopedic surgery as a model.
Most studies lack critical details like platelet concentrations
High variability in preparation protocols affects evidence quality
Model guidelines in orthopedic surgery could improve reporting standards.

Abstract

Biologics including platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) are increasingly utilized in plastic surgery for applications ranging from facial rejuvenation to wound healing.However, the literature currently contains heterogeneous reporting that undermines evidence synthesis and clinical application.A recent systematic review found that the vast majority of authors failed to disclose final platelet concentrations, concluding that systematic evaluation is limited by high heterogeneity in preparation protocols. 3Orthopedic surgery addressed this problem in 2017 by developing the Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO) guidelines through Delphi consensus, establishing

Bookmark

View Full Paper

Cite This Study

Whitford et al. (Wed,) studied this question.

synapsesocial.com/papers/69e7138bcb99343efc98d01a https://doi.org/https://doi.org/10.1016/j.bjps.2026.04.013

Bookmark

View Full Paper